CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein (Q47920379)

6 February 2018

title

CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein (English)

1 reference

6 February 2018

0 references

1 reference

Daniel Youssef Bargieri

object named as

Daniel Y Bargieri

5

0 references

Silvia B Boscardin

object named as

Silvia B Boscardin

6

0 references

author name string

Catarina J M Braga

1

1 reference

6 February 2018

Liliana M Massis

2

1 reference

6 February 2018

Maria E Sbrogio-Almeida

3

1 reference

6 February 2018

Bruna C G Alencar

4

1 reference

6 February 2018

Maurício M Rodrigues

7

1 reference

6 February 2018

Luís C S Ferreira

8

1 reference

6 February 2018

language of work or name

English

0 references

publication date

21 November 2009

1 reference

6 February 2018

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

6 February 2018

volume

28

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

page(s)

1373-1382

1 reference

6 February 2018

Structure of the bacterial flagellar protofilament and implications for a switch for supercoiling

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Segment IV of a Salmonella flagellin gene specifies flagellar antigen epitopes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Salmonella flagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Effects of flagellin on innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Cellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica Serovar Typhimurium to potentiate mucosal and systemic responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Induction of a cellular immune response to a defined T-cell epitope as an insert in the flagellin of a live vaccine strain of Salmonella.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Humoral immune response to flagellin requires T cells and activation of innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

The dog that did not bark: malaria vaccines without antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived en

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Measuring the frequency of mouse and human cytotoxic T cells by the Lysispot assay: independent regulation of cytokine secretion and short-term killing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Induction of adaptive immunity by flagellin does not require robust activation of innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Direct stimulation of tlr5+/+ CD11c+ cells is necessary for the adjuvant activity of flagellin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

Immune response to cholera toxin epitope inserted in Salmonella flagellin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.003

10.1016/J.VACCINE.2009.11.003

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

19932669

1 reference

6 February 2018